Researchers pioneer safe nanocarrier system for treating bacterial infections

  • 📰 physorg_com
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 55%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at Linköping University, Sweden.

Many drugs and drug candidates have proven highly effective in killing bacteria or tumor cells. The problem is that they also harm the patient, and they are therefore used very sparingly or not at all. When used to treat for instance cancer, they are delivered directly into the blood and spread throughout the body.

Over the past ten years, Frank Hernandez and his colleagues have made several discoveries paving the way for the method they developed to package nucleoside analogs so that these can be delivered in a safer way. They have, in multiple studies, examined the properties of a type of proteins called nucleases.

In their current study, the LiU researchers demonstrate how it works. They use the TOUCAN strategy on mice to kill Staphylococcus aureuswith the nucleoside analog floxuridine, which is used in health care to treat for instance colon cancer.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 388. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers connect Alzheimer's-associated genetic variants with brain cell functionResearch reveals new non-coding genetic variants associated with Alzheimer's disease functioning in microglia -- brain cells already implicated in the progression of this often-fatal neurodegenerative condition.
Source: ScienceDaily - 🏆 452. / 53 Read more »